Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02599324
Title A Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Pharmacyclics
Indications

gastroesophageal junction adenocarcinoma

transitional cell carcinoma

gastric adenocarcinoma

clear cell renal cell carcinoma

colorectal cancer

Therapies

Cetuximab + Ibrutinib

Ibrutinib + Paclitaxel

Everolimus + Ibrutinib

Docetaxel + Ibrutinib

Age Groups: senior | adult
Covered Countries USA | ESP

Additional content available in CKB BOOST